BridgeBio Pharma, Inc.

BBIO Nasdaq SEC CIK 1743881
Follow BridgeBio Pharma Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $353.2M +192.6% vs same quarter last year
Net income −$56.7M +69% vs same quarter last year
EPS, diluted −$0.42 +55.8% vs same quarter last year
Operating cash flow −$44.2M +59.7% vs same quarter last year
Revenue by quarter
$5.9M
$116.6M
$110.6M
$120.7M
$154.2M
$194.5M
$243.7M
$353.2M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income10 fiscal years
  • Revenue
  • Net income
−$1B−$500M$0$500M$1BFY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$502.1M−$732.9M
FY24$221.9M−$543.3M
FY23$9.3M−$653.3M
FY22$77.6M−$484.6M
FY21$69.7M−$586.5M
FY20$8.2M−$505.5M
FY19$40.6M−$288.6M
FY18-−$169.5M
FY17-−$43.8M
FY16--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−8000%−6000%−4000%−2000%0%2000%FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2595.8%−104.2%−146%
FY2498.3%−267.2%−244.9%
FY2373.7%−6528.8%−7021.9%
FY2295.6%−659.6%−624.1%
FY2195.5%−827.1%−841.2%
FY20-−5752%−6127.9%
FY19-−656.4%−711.5%
FY18---
FY17---
FY16---
Free cash flowOperating cash flow minus capital expenditure
−$600M−$400M−$200M$0FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$447M
FY24−$521.7M
FY23−$529M
FY22−$424.3M
FY21−$511.2M
FY20−$407.2M
FY19−$256.2M
FY18−$138.8M
FY17−$41M
FY16-
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$50M$100M$150M$200MFY17FY19FY21FY23FY25
Show the numbers
YearDividendsBuybacks
FY25-$48.3M
FY24-$0
FY23-$0
FY22-$0
FY21-$200M
FY20-$75M
FY19$997K-
FY18--
FY17$1.2M-
FY16--
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • BridgeBio Pharma
  • Healthcare median
−8000%−6000%−4000%−2000%0%FY17FY19FY21FY23FY25
Show the numbers
YearBridgeBio PharmaHealthcare median
FY25−146%−30.6%
FY24−244.9%−47%
FY23−7021.9%−58%
FY22−624.1%−80.4%
FY21−841.2%−71.8%
FY20−6127.9%−62.2%
FY19−711.5%−46.2%
FY18-−49.6%
FY17-−45.9%
FY16-−36%